Search Results - "Oturai, A. B."

Refine Results
  1. 1

    The neutrophil-to-lymphocyte ratio is associated with multiple sclerosis by Hasselbalch, IC, Søndergaard, HB, Koch-Henriksen, N, Olsson, A, Ullum, H, Sellebjerg, F, Oturai, AB

    “…Background Subtypes of white blood cell counts are known biomarkers of systemic inflammation and a high neutrophil-to-lymphocyte ratio (NLR) has been…”
    Get full text
    Journal Article
  2. 2

    Short-term, high-dose glucocorticoid treatment does not contribute to reduced bone mineral density in patients with multiple sclerosis by Olsson, A, Oturai, DB, Sørensen, PS, Oturai, PS, Oturai, AB

    Published in Multiple sclerosis (01-10-2015)
    “…Background: Patients with multiple sclerosis (MS) are at increased risk of reduced bone mineral density (BMD). A contributing factor might be treatment with…”
    Get full text
    Journal Article
  3. 3

    Early safety and efficacy of fingolimod treatment in Denmark by Voldsgaard, A., Koch‐Henriksen, N., Magyari, M., Sellebjerg, F., Sørensen, P. S., Oturai, A. B.

    Published in Acta neurologica Scandinavica (01-01-2017)
    “…Background Initiation of fingolimod treatment is associated with a transient decrease of heart rate, and atrioventricular (AV) conduction block may occur…”
    Get full text
    Journal Article
  4. 4

    Efficacy of natalizumab in multiple sclerosis patients with high disease activity: a Danish nationwide study by Oturai, A. B., Koch-Henriksen, N., Petersen, T., Jensen, P. E. H., Sellebjerg, F., Sorensen, P. S.

    Published in European journal of neurology (01-03-2009)
    “…Introduction:  Previous studies of natalizumab (Tysabri®) in relapsing multiple sclerosis (MS) patients have included patients with moderate disease activity…”
    Get full text
    Journal Article
  5. 5

    RGMA and IL21R show association with experimental inflammation and multiple sclerosis by Nohra, R, Beyeen, A D, Guo, J P, Khademi, M, Sundqvist, E, Hedreul, M T, Sellebjerg, F, Smestad, C, Oturai, A B, Harbo, H F, Wallström, E, Hillert, J, Alfredsson, L, Kockum, I, Jagodic, M, Lorentzen, J, Olsson, T

    Published in Genes and immunity (01-06-2010)
    “…Rat chromosome 1 harbors overlapping quantitative trait loci (QTL) for cytokine production and experimental models of inflammatory diseases. We fine-dissected…”
    Get full text
    Journal Article
  6. 6

    Soluble serum VCAM-1, whole blood mRNA expression and treatment response in natalizumab-treated multiple sclerosis by Petersen, ER, Søndergaard, HB, Oturai, AB, Jensen, PEH, Sorensen, PS, Sellebjerg, F, Börnsen, L

    Published in Multiple sclerosis and related disorders (01-11-2016)
    “…Abstract Background Natalizumab reduces disease activity in multiple sclerosis (MS). Natalizumab binds to the very late antigen-4 and inhibits vascular cell…”
    Get full text
    Journal Article
  7. 7

    Disease severity in Danish multiple sclerosis patients evaluated by MRI and three genetic markers (HLA-DRB11501, CCR5 deletion mutation, apolipoprotein E) by Schreiber, K, Oturai, A B, Ryder, L P, Madsen, H O, Jørgensen, O S, Svejgaard, A, Sorensen, P S

    Published in Multiple sclerosis (01-08-2002)
    “…As the understanding of the autoimmune inflammatory response in multiple sclerosis (MS) expands, polymorphic genes involved in this process become possible…”
    Get full text
    Journal Article
  8. 8

    Expression of melanoma cell adhesion molecule-1 (MCAM-1) in natalizumab-treated multiple sclerosis by Petersen, E.R., Ammitzbøll, C., Søndergaard, H.B., Oturai, A.B., Sørensen, P.S., Nilsson, A.C., Börnsen, L., von Essen, M., Sellebjerg, F.

    Published in Journal of neuroimmunology (15-12-2019)
    “…The objectives were to study the expression of very late antigen (VLA)-4, melanoma cell adhesion molecule-1 (MCAM-1) and activated leukocyte cell adhesion…”
    Get full text
    Journal Article
  9. 9

    Circulating levels of tight junction proteins in multiple sclerosis: Association with inflammation and disease activity before and after disease modifying therapy by Olsson, A., Gustavsen, S., Langkilde, A.R., Hansen, T.H., Sellebjerg, F., Bach Søndergaard, H., Oturai, A.B.

    Published in Multiple sclerosis and related disorders (01-09-2021)
    “…•Tight junction proteins contribute to maintenance of epithelial and endothelial barriers.•Circulating occludin levels are higher in newly diagnosed, untreated…”
    Get full text
    Journal Article
  10. 10

    Neurosurgery for Trigeminal Neuralgia: Comparison of Alcohol Block, Neurectomy, and Radiofrequency Coagulation by Oturai, A B, Jensen, K, Eriksen, J, Madsen, F

    Published in The Clinical journal of pain (01-12-1996)
    “…OBJECTIVES:We wished to assess the present condition of patients previously treated with a neurosurgical procedure or procedures for trigeminal neuralgia (TN)…”
    Get full text
    Journal Article
  11. 11

    Bone microarchitecture and bone mineral density in multiple sclerosis by Olsson, A., Oturai, A. B., Søndergaard, H. B., Sellebjerg, F., Oturai, P. S.

    Published in Acta neurologica Scandinavica (01-03-2018)
    “…Background Multiple sclerosis (MS) patients are at increased risk of reduced bone mineral density (BMD) and fractures. The aetiology of bone loss in MS is…”
    Get full text
    Journal Article
  12. 12

    Biomarkers of inflammation and epithelial barrier function in multiple sclerosis by Olsson, A., Gustavsen, S., Hasselbalch, I. Chenoufi, Langkilde, A.R., Sellebjerg, F., Oturai, A.B., Søndergaard, H. Bach

    Published in Multiple sclerosis and related disorders (01-11-2020)
    “…•Serum calprotectin and NfL levels are higher in MS patients compared with healthy controls•Serum calprotectin levels are associated with disease activity in…”
    Get full text
    Journal Article
  13. 13

    Illegal cannabis use is common among Danes with multiple sclerosis by Gustavsen, S., Søndergaard, H.B., Andresen, S.R., Magyari, M., Sørensen, P.S., Sellebjerg, F., Oturai, A.B.

    Published in Multiple sclerosis and related disorders (01-08-2019)
    “…•Illegal cannabis use is common among Danes with multiple sclerosis.•Cannabis was used within the past year (current user) by 21%.•21% of current users…”
    Get full text
    Journal Article
  14. 14

    Prediction of response to interferon therapy in multiple sclerosis by Sellebjerg, F., Søndergaard, H. B., Koch-Henriksen, N., Sørensen, P. S., Oturai, A. B.

    Published in Acta neurologica Scandinavica (01-10-2014)
    “…Objective Single nucleotide polymorphisms (SNPs) in the genes encoding interferon response factor (IRF)‐5, IRF‐8 and glypican‐5 (GPC5) have been associated…”
    Get full text
    Journal Article
  15. 15

    Genetic polymorphisms of dsRNA ligating pattern recognition receptors TLR3, MDA5, and RIG-I. Association with systemic lupus erythematosus and clinical phenotypes by Enevold, C., Kjær, L., Nielsen, C. H., Voss, A., Jacobsen, R. S., Hermansen, M. L. F., Redder, L., Oturai, A. B., Jensen, P. E., Bendtzen, K., Jacobsen, S.

    Published in Rheumatology international (01-10-2014)
    “…This study aimed to demonstrate possible associations between genetic polymorphisms in Toll-like receptor 3, interferon induced with helicase C domain 1…”
    Get full text
    Journal Article
  16. 16

    The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis by Møller, M., Søndergaard, H. B., Koch-Henriksen, N., Sorensen, P. S., Sellebjerg, F., Oturai, A. B.

    Published in Acta neurologica Scandinavica (01-01-2014)
    “…Objective The chemokine receptor CCR5 may be important for the recruitment of pathogenic T cells to the CNS in multiple sclerosis (MS). We hypothesized that…”
    Get full text
    Journal Article
  17. 17

    Shift Work At Young Age is Associated with Increased Risk of Multiple Sclerosis In A Danish Population by Gustavsen, S, Søndergaard, H.B, Oturai, D.B, Laursen, B, Laursen, J.H, Magyari, M, Ullum, H, Larsen, M.H, Sellebjerg, F, Oturai, A.B

    Published in Multiple sclerosis and related disorders (01-09-2016)
    “…Abstract Background Epidemiological studies suggest an important role for environmental factors in developing multiple sclerosis (MS). Furthermore several…”
    Get full text
    Journal Article
  18. 18

    Identity-by-descent mapping in a Scandinavian multiple sclerosis cohort by Westerlind, Helga, Imrell, Kerstin, Ramanujam, Ryan, Myhr, Kjell-Morten, Celius, Elisabeth Gulowsen, Harbo, Hanne F, Oturai, Annette Bang, Hamsten, Anders, Alfredsson, Lars, Olsson, Tomas, Kockum, Ingrid, Koski, Timo, Hillert, Jan

    Published in European journal of human genetics : EJHG (01-05-2015)
    “…In an attempt to map chromosomal regions carrying rare gene variants contributing to the risk of multiple sclerosis (MS), we identified segments shared…”
    Get full text
    Journal Article
  19. 19

    The chemokine receptor CCR5 Delta 32 allele in natalizumab-treated multiple sclerosis by Moeller, M, Soendergaard, H B, Koch-Henriksen, N, Sorensen, P S, Sellebjerg, F, Oturai, AB

    Published in Acta neurologica Scandinavica (01-01-2014)
    “…The chemokine receptor CCR5 may be important for the recruitment of pathogenic T cells to the CNS in multiple sclerosis (MS). We hypothesized that this…”
    Get full text
    Journal Article
  20. 20